ADMA Stock, ADMA Biologics Inc Information
Stock Information
Get ADMA Alerts
News, Short Squeeze, Breakout and More Instantly...
About ADMA Biologics Inc
ADMA Biologics is a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma based biologics for the treatment and prevention of certain infectious diseases. Our targeted patient populations include immune compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune suppressed for medical reasons. Our product candidates are intended to be used by physician specialists focused on caring for immune compromised patients with infectious diseases. ADMA also operates ADMA BioCenters, an FDA licensed, GHA certified source plasma collection facility which provides a portion of blood plasma for the manufacture of the our lead product candidate RI .